Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis

Clinical trial NCT06453317 · RECRUITING

Trial details

NCT number: NCT06453317
Sponsor: Medical University of Lodz
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis Inflammatory Bowel Diseases

Start date: 2025-02-17
Primary completion: 2028-04-30
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.